Two Reasons Aldeyra Therapeutics (ALDX) SOLACE Read Through Should Be Minimal, PT Cut to $24 at Citi
Tweet Send to a Friend
Citi analyst Yigal Nochomovitz lowered the price target on Aldeyra Therapeutics (NASDAQ: ALDX) to $24.00 (from $28.00) and sees a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
